Merck & Co. (Non-US Commercial Rights of Aggrastat) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Merck & Co. (Non-US Commercial Rights of Aggrastat) General Information

Description

Commercial rights of a cardiovascular product outside of the United States. The drug is used to treat acute coronary syndrome in patients who are managed medically and those undergoing percutaneous transluminal coronary angioplasty (PTCA).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kenilworth, NJ
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Kenilworth, NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck & Co. (Non-US Commercial Rights of Aggrastat) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck & Co. (Non-US Commercial Rights of Aggrastat)‘s full profile, request access.

Request a free trial

Merck & Co. (Non-US Commercial Rights of Aggrastat) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merck & Co. (Non-US Commercial Rights of Aggrastat)‘s full profile, request access.

Request a free trial

Merck & Co. (Non-US Commercial Rights of Aggrastat) FAQs

  • Where is Merck & Co. (Non-US Commercial Rights of Aggrastat) headquartered?

    Merck & Co. (Non-US Commercial Rights of Aggrastat) is headquartered in Kenilworth, NJ.

  • What industry is Merck & Co. (Non-US Commercial Rights of Aggrastat) in?

    Merck & Co. (Non-US Commercial Rights of Aggrastat)’s primary industry is Buildings and Property.

  • Is Merck & Co. (Non-US Commercial Rights of Aggrastat) a private or public company?

    Merck & Co. (Non-US Commercial Rights of Aggrastat) is a Private company.

  • What is Merck & Co. (Non-US Commercial Rights of Aggrastat)’s current revenue?

    The current revenue for Merck & Co. (Non-US Commercial Rights of Aggrastat) is .

  • Who are Merck & Co. (Non-US Commercial Rights of Aggrastat)’s investors?

    Merck & Co. has invested in Merck & Co. (Non-US Commercial Rights of Aggrastat).

  • When was Merck & Co. (Non-US Commercial Rights of Aggrastat) acquired?

    Merck & Co. (Non-US Commercial Rights of Aggrastat) was acquired on 30-Jan-2008.

  • Who acquired Merck & Co. (Non-US Commercial Rights of Aggrastat)?

    Merck & Co. (Non-US Commercial Rights of Aggrastat) was acquired by Iroko Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process